Back To Search Instructions
Protocols
6 protocols meet the specified criteria
Phase: I/II
Protocol No.TitleStatus
1100000429Phase 1b, Escalating Dose Study of AVL-292, a Bruton's Tyrosine Kinase (Btk) Inhibitor, as Monotherapy in Subjects with Relapsed and/or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's MacroglobulinemiaOpen
1200000080NSAID Effects on Clinical and Imaging Breast BiomarkersOpen
1200000288A Phase II Exploratory Study of PXD101 Followed by Zevalin in Patients with Relapsed Aggressive High-Risk Lymphoma (Stage 1)Open
1300000305A Phase 1b/2, Multicenter, Open-label Trial to Evaluate the Safety and Efficacy of Talimogene Laherparepvec and Ipilimumab Compared to Ipilimumab Alone in Subjects With Previously Untreated, Unresectable, Stage IIIb-IV MelanomaOpen
1300000378A Phase Ib/II Trial of ALT-801 in Combination with Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer Open
1300000430A Phase I/II, Two-Part, Multicenter Study to Evaluate the Safety and Efficacy of M402 in Combination with nab-Paclitaxel and Gemcitabine in Patients with Metastatic Pancreatic CancerOpen